Mölndal, Sweden

Ulrik Jurva

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Ulrik Jurva

Introduction

Ulrik Jurva, an accomplished inventor based in Mölndal, Sweden, has made significant contributions in the field of medicinal chemistry and pharmacology. With a total of 5 patents to his name, his work focuses on developing therapeutic compounds aimed at addressing critical health issues.

Latest Patents

Among Ulrik's noteworthy inventions are the 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones, which serve as inhibitors of myeloperoxidase. These compounds, along with their pharmaceutically acceptable salts and compositions, are outlined in his latest patents. They demonstrate a promising use in therapy for treating or preventing cardiovascular disorders, including heart failure and coronary artery disease. The development of these inhibitors reflects Ulrik's commitment to addressing significant health challenges through innovative science.

Career Highlights

Ulrik Jurva's career is marked by his association with AstraZeneca AB, a leading global pharmaceutical company. His work there exemplifies his dedication to advancing medical research and therapeutics aimed at improving patient outcomes.

Collaborations

Throughout his career, Ulrik has collaborated with talented individuals, including coworkers Tord Bertil Inghardt and Petra Johannesson. These partnerships have undoubtedly enriched his research endeavors, contributing to the development of innovative solutions in the medical field.

Conclusion

In summary, Ulrik Jurva stands out as a noteworthy inventor whose contributions to pharmacology have the potential to make a lasting impact on health care. His innovative approaches and collaborative efforts within AstraZeneca AB and beyond highlight his significant role in advancing medicinal chemistry to tackle prevalent cardiovascular issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…